Literature DB >> 1984342

Resting and total energy expenditure in patients with inflammatory bowel disease.

R F Kushner1, D A Schoeller.   

Abstract

Patients with inflammatory bowel disease often present with weight loss. Among possible causes, an elevated energy expenditure has frequently been suggested but is the least documented. In this study resting metabolic rate (RMR) and total daily energy expenditure (TDEE) were measured in 15 outpatients with inflammatory bowel diseases and in eight healthy control subjects. Measured RMR as a percentage of that predicted from fat-free mass was not significantly different for control subjects (102 +/- 9.8%, mean +/- SD) and patients (100 +/- 13.3%). TDEE, expressed as a multiple of RMR, was 1.70 +/- 0.31 for control subjects and 1.78 +/- 0.24 for patients. When patients were subgrouped as greater than or equal to 90% or less than 90% desirable body weight, a mean increase over RMR predicted from fat-free mass was seen in the underweight patients (106 +/- 9.3%) but not in normal-weight patients (99.0 +/- 15.6%). Mean TDEE/RMR values for the patient subgroups were 1.70 +/- 0.30 and 1.88 +/- 0.08, respectively. We conclude that stable outpatients with inflammatory bowel disease have only a minimal increase in energy needs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984342     DOI: 10.1093/ajcn/53.1.161

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Dietary energy requirements in relatively healthy maintenance hemodialysis patients estimated from long-term metabolic studies.

Authors:  Anuja Shah; Rachelle Bross; Bryan B Shapiro; Gillian Morrison; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2016-02-10       Impact factor: 7.045

2.  Impact of enteral nutrition on energy metabolism in patients with Crohn's disease.

Authors:  Jie Zhao; Jian-Ning Dong; Jian-Feng Gong; Hong-Gang Wang; Yi Li; Liang Zhang; Lu-Gen Zuo; Yun Feng; Li-Li Gu; Ning Li; Jie-Shou Li; Wei-Ming Zhu
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.

Authors:  M Azcue; M Rashid; A Griffiths; P B Pencharz
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Juvenile onset inflammatory bowel disease: height and body mass index in adult life.

Authors:  A Ferguson; D M Sedgwick
Journal:  BMJ       Date:  1994-05-14

5.  Energy expenditure in Japanese patients with severe or moderate ulcerative colitis.

Authors:  Masaya Sasaki; Tomoko Johtatsu; Mika Kurihara; Hiromi Iwakawa; Toshihiro Tanaka; Shigeki Bamba; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Akira Andoh
Journal:  J Clin Biochem Nutr       Date:  2010-04-23       Impact factor: 3.114

6.  Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.

Authors:  A Diamanti; M S Basso; M Gambarara; B Papadatou; F Bracci; C Noto; M Castro
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

7.  Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.

Authors:  Dawn Wiese; Bret Lashner; Douglas Seidner
Journal:  Nutr Clin Pract       Date:  2008 Oct-Nov       Impact factor: 3.080

8.  Increased resting lipid oxidation in Crohn's disease.

Authors:  G Mingrone; A V Greco; G Benedetti; E Capristo; R Semeraro; G Zoli; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

9.  Increased energy expenditure in growing adolescents with Crohn's disease.

Authors:  G Zoli; P H Katelaris; J Garrow; G Gasbarrini; M J Farthing
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

10.  Energy metabolism in Japanese patients with Crohn's disease.

Authors:  Masaya Sasaki; Tomoko Johtatsu; Mika Kurihara; Hiromi Iwakawa; Toshihiro Tanaka; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Akira Andoh
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.